Use: Labeled indications
- PIRNUO cream is indicated for the treatment of secondarily infected traumatic skin lesions (up to 10 cm in length or 100 cm 2 in area) due to susceptible isolates of Staphylococcus aureus (S. aureus) and Streptococcus…
Full indications and usage US FDA label
1 INDICATIONS AND USAGE PIRNUO cream is indicated for the treatment of secondarily infected traumatic skin lesions (up to 10 cm in length or 100 cm 2 in area) due to susceptible isolates of Staphylococcus aureus (S. aureus) and Streptococcus pyogenes (S. pyogenes). PIRNUO cream is an RNA synthetase inhibitor antibacterial indicated for the treatment of secondarily infected traumatic skin lesions (up to 10 cm in length or 100 cm 2 in area) due to susceptible isolates of Staphylococcus aureus and Streptococcus pyogenes. (1)
Contraindications
4 CONTRAINDICATIONS PIRNUO cream is contraindicated in patients with known hypersensitivity to mupirocin or any of the excipients of PIRNUO cream. • Known hypersensitivity to mupirocin or any of the excipients of PIRNUO cream. (4)
US FDA labelDosing: Adult
Dosage and administration (US label) US FDA label
2 DOSAGE AND ADMINISTRATION
- For Topical Use Only.
- Apply a small amount of PIRNUO cream, with a cotton swab or gauze pad, to the affected area 3 times daily for 10 days.
- Cover the treated area with gauze dressing if desired.
- Re-evaluate patients not showing a clinical response within 3 to 5 days.
- PIRNUO cream is not for intranasal, ophthalmic, or other mucosal use [see Warnings and Precautions (5.2, 5.6)].
- Do not apply PIRNUO cream concurrently with any other lotions, creams, or ointments [see Clinical Pharmacology (12.3)].
- For Topical Use Only. (2)
- Apply a small amount of PIRNUO cream, with a cotton swab or gauze pad, to the affected area 3 times daily for 10 days. (2)
- Re-evaluate patients not showing a clinical response within 3 to 5 days. (2)
- Not for intranasal, ophthalmic, or other mucosal use. (2)
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosing: Pediatric
Pediatric use (US label) US FDA label
8.4 Pediatric Use The safety and effectiveness of mupirocin cream have been established in the age-groups of 3 months to 16 years. Use of PIRNUO cream in these age-groups is supported by evidence from adequate and well-controlled trials of mupirocin cream in adults with additional data from 93 pediatric subjects studied as part of the pivotal trials in adults [see Clinical Studies (14)].
Dosing: Older adult
Geriatric use (US label) US FDA label
8.5 Geriatric Use In 2 adequate and well-controlled trials, 30 subjects older than 65 years were treated with mupirocin cream. No overall difference in the efficacy or safety of mupirocin cream was observed in this patient population when compared with that observed in younger patients.
Dosage forms
Philippines
- Ointment: 20 mg/g
- Topical ointment: 2 g/100 g, 20 mg/g
- W/w) topical ointment: 20 mg/g (2 %
- Cream: 20 mg/g
- Topical cream: 20 mg/g
- W/w) ointment: 20 mg/g (2 %
- ) ointment: 20 mg/g
- ) topical ointment: 2 g/100 g
- Gram ointment: 20 mg
- Per gram ointment: 20 mg
and 1 more forms; see the products table.
Registered products in the Philippines
167 products registered with the Food and Drug Administration (FDA) Philippines list Mupirocin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products167
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
AccebactMupirocin | 20mg/g (2%w/w) Topical CreamAluminum Tube with HDPE Cap x 5g, 10g ang 15g (Box of 1's) | Rx | Opal Laboratories Pvt. Ltd.Pakistan | Accesspoint International Trading Inc.Importer: Accesspoint International Trading, Inc. | DRP-12992 | Nov 14, 2027 | |
AccebactMupirocin | 20mg/g (2%w/w) Topical OintmentAluminum Tube with HDPE Cap x 5g, 10g ang 15g (Box of 1's) | OTC | Opal Laboratories Pvt. Ltd.Pakistan | Accesspoint International Trading Inc.Importer: Accesspoint International Trading, Inc. | DRP-12991 | Nov 14, 2027 | |
AdocinMupirocin | 2% w/w Topical OintmentAluminum Collapsible Tube x 15g (Box of 1's) Aluminum Collapsible Tube x 5g (Box of 1's) | Rx | Rhydburg Pharmaceuticals Ltd.India | Genedrift Philippines OPC | DRP-13956 | May 25, 2028 | |
B-BactMupirocin | 20 mg/g (2%w/w) OintmentAluminum Tube with White Screw Plastic Cap x 5 g | OTC | Wallace Pharmaceuticals Pvt. Ltd.India | Biocare lifesciences Inc. | DR-XY47767 | Feb 28, 2027 | |
BacrocinMupirocin | 20 mg/g (2% w/w) OintmentCollapsible Aluminum Tube x 5 g (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India | Rule Med Pharma Corp.Importer: Teramedix Pharma Trading Inc. | DRP-14268-03 | Feb 7, 2031 | |
BacselMupirocin | 20 mg/g (2% w/w) Topical OintmentWhite Laminated Plastic Tube with Cap x 5 g (Box of 1's) | OTC | S Kant Healthcare Ltd.India | New Seammed IncImporter: Medinova Pharmaceutical Inc. | DRP-15716-03 | Sep 5, 2029 | |
BactendMupirocin | 20 mg/g (2% w/w) Ointment5 g Collapsible Aluminum Tube (Box of 1's) | Rx | Front Pharmaceuticals PLCChina | Hexagon Pharmaceuticals | DRP-11651 | Oct 22, 2031 | |
BactendMupirocin | 20mg/gram (2%) Ointment5 g collapsible aluminum tube (Box of 1’s) | Rx | Front Pharmaceutical PLCChina | Hexagon Pharmaceuticals | DR-XY47489 | Nov 16, 2026Past listed date | |
BacteraseMupirocin | 20 mg / g (2% w/w) OintmentCollapsible Aluminum Tube x 5 g (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India | One Technodrug Life Sciences Inc.Importer: Teramedix Pharma Trading Inc. | DRP-14268-02 | Mar 2, 2031 | |
BactestopMupirocin | 20 mg/g (2% w/w) Ointment5 g Aluminum Tube (Box of 1's) | Rx | Agio Pharmaceuticals Ltd.India | TGP Pharma Inc.Importer: Ambica International Corporation | DRP-3840-04 | Nov 22, 2028 | |
BactestopMupirocin | 20mg/g (2%w/w) Topical OintmentLaminated Tube x 5 g (Box of 1's) | OTC | East African (India) OverseasIndia | TGP Pharma Inc.Importer: Ambica International Corporation | DRP-13828-01 | Apr 27, 2028 | |
BacticinMupirocin | 20 mg/g (2% w/w) OintmentAluminum Collapsible Tube x 10 g (Box of 1's) | OTC | Next Wave (India)India | Biocare Lifesciences, Inc. | DRP-16269 | Jan 17, 2030 | |
BactierMupirocin | 20 mg/g (2% w/w) Ointment5 g Aluminum Collapsible Tube with White PE Cap (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India | Quad-Gen PharmaceuticalsImporter: Pharmakon Biotec Inc. | DRP-8263-07 | Jul 10, 2029 | |
BactifreeMupirocin | 2% CreamCollapsible Aluminum Tube x 5 g (Box of 1's) | Rx | Amherst Laboratories, Inc.Philippines | Trader: UNILAB, INC. | DR-XY37246 | Oct 15, 2028 | |
BactifreeMupirocin | 20 mg/g (2% w/w) OintmentCollapsible Aluminium Tube (5 g and 10 g) | OTC | Amherst Laboratories, Inc.Philippines | Trader: UNILAB, Inc. | DRP-1138 | Jun 7, 2027 | |
BactigardMupirocin | 20 mg/g (2%w/w) Topical OintmentAluminum Tube with White Screw Cap x 5g, 10g, 15g, 20g (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | — | DRP-17272 | Nov 5, 2030 | |
BactiproMupirocin | 20 mg / g (2 % w/w) Ointment5-g Aluminum Collapsible Tube with White PE Cap (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India | Zion Pharmaceutical Product DistributionImporter: Pharmakon Biotec Inc. | DRP-8263-13 | Jul 10, 2029 | |
Bactofer-OMupirocin | 20 mg / g (2% w / w) Topical OintmentAluminum Tube with HDPE Cap x 5 g (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Ferjan Healthlink Philipines Inc.Importer: Accesspoint International Trading Inc. | DRP-12991-05 | Nov 14, 2027 | |
BactofixMupirocin | 20 mg/g (2% w/w) OintmentAluminum Collapsible Tube Sealed with PE Screw Cap x 5 g and 15 g (Box of 1's) | Rx | Maneesh Pharmaceuticals Ltd.India | Pharma-Surrey International, Inc. | DRP-11589 | Mar 30, 2027 | |
BactopicMupirocin | 20 mg/g (2% w/w) OintmentAluminum Tube x 15 g Box of 1's; Aluminum Tube x 5 g Box of 1's; Aluminum Tube x 5 g Box of 1's (as Physician's Sample) | Rx | Kusum Healthcare Pvt. Ltd.India | Kusum Healthcare Private Limited Branch Office | DR-XY47174 | Feb 19, 2031 | |
BactosunMupirocin | 20 mg/g (2% w/w) OintmentAluminium Collapsible Tube x 15 g (Box of 1's) | OTC | Rhydburg Pharmaceuticals Ltd.India | Genedrift Philippines OPCTrader: Sun Elastomers Private Limited. | DRP-15557 | Aug 1, 2029 | |
BactreatMupirocin | 20 mg / g (2%) ointmentAluminum Collapsible Tube x 5 g, 10 g and 15 g (Box of 1's); Aluminum Collapsible Tube x 2.5 g (Physician's sample) (Box of 1's) | Rx | Yash Medicare Private LimitedIndia | Eon Pharmatek, Inc.Trader: I-Care Pharmaceuticals Pvt. Ltd | DRP-15736 | Jul 23, 2029 | |
BactreatMupirocin | 20 mg/g (2%) OintmentAluminum Collapsible Tube x 5 g, 10 g and 15 g (Box of 1's); Aluminum Collapsible Tube x 2.5 g (Physician's sample) (Box of 1's) | Rx | Yash Medicare Private LimitedIndia | Eon Pharmatek, Inc.Trader: I-Care Pharmaceuticals Pvt. Ltd. | DR-XY43560 | Jul 23, 2029 | |
BactrexinMupirocin | 20mg/g (2% w/w) OintmentAluminium Collapsible Tube x 5 g, 10 g, and 15 g (Box of l's) | OTC | Next Wave (India)India | Aarex Pharma Distributor | DRP-12706 | Oct 7, 2027 | |
BactribanMupirocin | 20 mg/g (2% w/w) Topical OintmentAluminum Collapsible Tube x 15g (Box of 1's) Aluminum Collapsible Tube x 5g (Box of 1's) | Rx | Rhydburg Pharmaceuticals Ltd.India | Genedrift Philippines OPC | DRP-13955 | May 25, 2028 | |
BactridermMupirocin | 20 mg/g (2% w/w) Topical OintmentAluminum Collapsible Tube x 5 g and 15 g (Box of 1's) | Rx | U Square Lifesciences Pvt. Ltd.India | ENDURE MEDICAL, INC.Importer: SKINGEN BIOTECH, INC. | DR-XY40753 | Mar 22, 2027 | |
BactrigonMupirocin | 20 mg/g (2% w/w) OintmentCollapsible Aluminum Tube x 5 g (Box of 1's) | OTC | Magbro Healthcare Pvt. Ltd.India | Kaufmann Pharma, Inc.Importer: Teramedix Pharma Trading Inc. | DRP-14268-04 | Feb 7, 2031 | |
BactrigonMupirocin | 20 mg/g (2% w/w) Ointment5 g Aluminum Tube (Box of 1's) | Rx | Agio Pharmaceuticals Ltd.India | Kaufmann Pharma Inc.Importer: Ambica International Corporation | DRP-3840-03 | Nov 22, 2028 | |
BactrihealMupirocin | 20 mg/g (2 % w/w) OintmentAluminum Tube x 5 g (Box of 1's) | Rx | KLM Laboratories Pvt. Ltd.India | I-Heal Pharmaceutical CorporationImporter: AMB HK Enterprises Inc. | DRP-13921-01 | May 17, 2028 | |
BactrobanMupirocin | 20 mg/g (2% w/w) OintmentCollapsible Aluminum Tube with Polypropylene Cap x 5 g and 15 g (Box of 1's) | Rx | Glaxo Operations UK Ltd. Trading as Glaxo Wellcome OperationsUnited Kingdom | Importer: GlaxoSmithKline Philippines, Inc. | DRP-4193 | May 11, 2031 | |
BactrodixMupirocin | 20 mg/g (2% w/w) Ointment5-g Aluminum Collapsible Tube with White PE Cap (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India | Zeldix Pharma Inc.Importer: Pharmakon Biotec Inc. | DRP-8263-12 | Jul 10, 2029 | |
BactrofarMupirocin | 20 mg/g (2% w/w) Ointment5 g Laminated Plastic Tube with PE screwed cap (Box of 1's) | Rx | Scott-Edil Pharmacia LimitedIndia | Pharmakon Biotec Inc. | DRP-7367 | Sep 7, 2031 | |
BactrostarMupirocin | 20 mg/g (2% w/w) OintmentAluminum Tube x 5 g (Box of 1's) | Rx | Rhydburg Pharmaceuticals LimitedIndia | Pharmastar Int'l Trading Corp.Trader: Sheer Essentials | DRP-13428 | Feb 15, 2028 | |
BarozinMupirocin | 20 mg/g (2% w/w) Ointment5 g and 15 g Lami Tube (Box of 1’s) | Rx | Nanz Med Science Pharma Pvt. Ltd.India | Pharma-Surrey International, Inc. | DRP-13043 | Nov 24, 2027 | |
BatribanMupirocin | 20 mg/g (2% w/w) Topical OintmentLaminated PE Tube x 5 g, 10 g and 15 g (Box of l's) | OTC | Mascot Health Series Pvt. Ltd.India | Importer: Wellchem Pharmaceutical Products | DRP-11277 | Feb 22, 2027 | |
BupironMupirocin | 20 mg/g (2% w/w) OintmentAluminum Tube x 15g (Box of 1's) | OTC | Rhydburg Pharmaceuticals LimitedIndia | Genedrift Philippines OPCTrader: BSD Global Pte. Ltd. | DRP-13659 | Mar 29, 2028 | |
BusidMupirocin | 20 mg/g (2% w/w) OintmentLaminated Tube x 15g (Box of 1's) | OTC | Rhydburg Pharmaceuticals LimitedIndia | Genedrift Philippines OPCTrader: BSD Global Pte. Ltd. | DRP-13660 | Mar 29, 2028 | |
CanderttMupirocin | 20 mg/g (2% w/w) Topical OintmentLami Tube x 5 g (Box of 1's) | OTC | Helios Pharmaceuticals (Division of P.K.T.P Private Limited)India | AGB Pharmaceutical Trading and Consultancy CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-16482 | Apr 8, 2030 | |
CintrobanMupirocin | 20 mg/g (2% w/w) OintmentLaminated Plastic Tube x 5 g, 10 g and 15 g (Box of 1's) | OTC | Blossom Pharmaceuticals.India | Wellchem Pharmaceutical Products | DRP-14887 | Feb 8, 2029 | |
CutisproMupirocin | 2% w/w (20 mg/g) OintmentLaminated Tube with white cap x 5 g (Box of 1's) | OTC | S Kant Healthcare LimitedIndia | Ambica International Corporation | DRP-17153 | Oct 3, 2030 | |
DellcinMupirocin | 20 mg/g (2% w/w) Topical OintmentAluminum Tube with Cap x 5 g and 15 g (Box of 1's) | OTC | PSA Chemicals & Pharmaceuticals Pvt. Ltd.India | 1 Med PharmaImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-14964-03 | Mar 7, 2029 | |
DermpibacMupirocin | 20 mg/g (2% w/w) Ointment5 g Aluminum Tube (Box of 1's) | Rx | Agio Pharmaceuticals Ltd.India | D&G PharmaImporter: Ambica International Corporation | DRP-3840-10 | Nov 22, 2028 | |
DiapurocinMupirocin | 20 mg/g (2% w/w) OintmentAluminum Tube x 5 g (Box of 1's) | Rx | Agio Pharmaceuticals Ltd.India | Diafarm Inc.Importer: Ambica International Corporation | DRP-3840-09 | Nov 22, 2028 | |
DomidermMupirocin | 20 mg/g (2% w/w) Ointment5-g Aluminum Collapsible Tube with White PE Cap (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India 174101 | Medko Pharmaceuticals DistributorImporter: Pharmakon Biotec Inc. | DRP-8263-16 | Jul 10, 2029 | |
EL-PirocinMupirocin | 20 mg/g (2% w/w) CreamLami Tube x 5 g & 15 g | OTC | Kwality Pharmaceuticals Ltd.India | Jehu-Nissi Pharmaceuticals Sales IncImporter: Pharma-Surrey International, Inc. | DRP-15022-02 | Apr 4, 2029 | |
El-RocinMupirocin | 20 mg/g (2% w/w) Topical OintmentAluminum Collapsible Tube x 15 g and 5 g (Box of 1's) | Rx | Rhydburg Pharmaceuticals LimitedIndia | Jehu-Nissi Pharmaceuticals Sales Inc.Importer: Starpharm, Inc. | DRP-13956-01 | May 25, 2028 | |
FlovicideMupirocin | 20 mg/g (2% w/w) OintmentAluminum Tube x 5 g (Box of 1's) | Rx | Agio Pharmaceuticals Ltd.India | Guimhealth Pharmaceutical Distributor and DrugstoreImporter: Ambica International Corporation | DRP-3840-08 | Nov 22, 2028 | |
FoskinaMupirocin | 2 g /100 g (2% w/w) Topical OintmentCollapsible Aluminum Tube x 5 g and 15 g (Box of 1's) | Rx | Glenmark Pharmaceuticals Ltd.India | Glenmark Philippines, Inc. | DRP-3686 | May 26, 2031 | |
FoskinaMupirocin | 20 mg/g (2% w/w) CreamAluminum Collapsible Tube x 5g and 15g Box of 1's | Rx | Glenmark Pharmaceuticals Ltd.India | Glenmark Philippines, Inc. | DRP-7858 | May 30, 2028 | |
FoskinaMupirocin | 20 mg/g (2%w/w) Topical OintmentPrinted Aluminum Collapsible Tube with Cap x 15 g (Box of 1's) | OTC | Glenmark Pharmaceuticals Ltd.India | Glenmark Philippines, Inc. | DRP-11995 | May 27, 2027 | |
GorocinMupirocin | 20 mg/g (2% w/w) OintmentAluminum Tube x 5g (Box of 1's) | Rx | Rhydburg Pharmaceuticals LimitedIndia | Go-Life PharmaImporter: Dreamax IncorporatedTrader: Oak And Zen | DRP-13469-01 | Feb 23, 2028 | |
HealocinMupirocin | 20 mg / g (2% w/w) Ointment5-g Aluminum Collapsible Tube with White PE Cap (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-8263-14 | Jul 10, 2029 | |
KaptrobanMupirocin | 20mg/g (2% w/w) OintmentAluminum Collapsible Tube x 5 g and 15 g | Rx | Dupen Laboratories Pvt. Ltd.India | Khriz Pharma Trading Inc | DR-XY45353 | May 3, 2031 | |
KodabactMupirocin | 20mg/g (2% w/w) Topical OintmentAluminum Tube with HDPE cap x 5g, 10g and 15g (Box of 1's) | OTC | Opal Laboratories (Pvt.) LimitedPakistan | Kodapharm Med Corp.Importer: Accesspoint International Trading Inc. | DRP-12991-01 | Nov 14, 2027 | |
LinprobanMupirocin | 20 mg/g (2% w/w) Ointment5 g Aluminum Tube (Box of 1's) | Rx | Agio Pharmaceuticals Ltd.India | Linmer Pharma IncorporatedImporter: Ambica International Corporation | DRP-3840-07 | Nov 22, 2028 | |
MicroscotMupirocin | 20 mg/g (2% w/w) OintmentLaminated PE Plastic Tube x 5 g and 15 g Box of 1's | Rx | Scott-Edil Pharmacia LimitedIndia | Greencore Pharma Inc. | DRP-6195 | Jun 24, 2031 | |
MicrotopMupirocin | 20 mg/g (2% w/w) Topical OintmentAluminum tube x 5 g (Box of 1's) | Rx | Aurochem Laboratories (I) Pvt. Ltd.India | Biocare Lifesciences, Inc. | DRP-17293 | Nov 12, 2030 | |
MirocidMupirocin | 20 mg/g (2%) OintmentAluminum Tube x 5 g and 10 g (Box of 1's) | Rx | Biopharma Laboratories LimitedBangladesh | JF Draf Pharmaceuticals Corporation | DRP-3672 | Mar 20, 2027 | |
MucinMupirocin (As Calcium Dihydrate) | 20 mg/g (2% w/w) CreamAluminum Collapsible Tube Sealed with PP Cap x 5 g (Box of 1's) | Rx | Global Pharmaceuticals (Pvt.) Ltd.Pakistan | Surestep Pharmaceuticals, Inc. | DR-XY47843 | Mar 30, 2027 | |
MucinMupirocin | 20 mg/g (2% w/w) OintmentCollapsible Aluminum Tube with White Cap x 5 g (Box of l's) | OTC | Global Pharmaceuticals (Pvt.) Ltd.Pakistan | Surestep Pharmaceuticals, Inc. | DR-XY47899 | Apr 4, 2027 | |
MufierMupirocin | 20 mg/g (2% w/w) Topical OintmentAluminum Collapsible Tube x 20g (Box of 1's) | OTC | Kwality Pharmaceutical Ltd.India | Fier Pharma Trading Inc.Importer: PORS Pharma Trading | DRP-13057-01 | Nov 23, 2027 | |
MukantMupirocin | 20 mg/g (2% w/w) OintmentLaminated Tube x 10 g (Box of 1's) | OTC | S Kant Healthcare LimitedIndia | Aglobal Care, Inc. | DRP-16460 | Mar 18, 2027 | |
MuodermMupirocin | 20 mg/g (2% w/w) Topical Ointment5 g and 15 g Aluminum tube with white HDPE plastic cap (Box of 1's) | Rx | Icpa Health Products LimitedIndia | Macropharma Corporation | DRP-17143 | Oct 7, 2030 | |
Mupi-medMupirocin | 20 mg/g (2% w/w) Ointment5 g Aluminum Tube (Box of 1's) | Rx | Agio Pharmaceuticals Ltd.India | Diafarm Inc.Importer: Ambica International Corporation | DRP-3840-02 | Nov 22, 2028 | |
MupiactMupirocin | 20 mg/g (2% w/w) Ointment5 g Aluminum Tube (Box of 1’s) | OTC | Curetech SkincareIndia | Preventia Healthcare Inc.Importer: Ambica International Corporation | DRP-13368-01 | Feb 21, 2028 | |
MupibanMupirocin | 20 mg/g (2% w/w) Ointment5 g Aluminum Tube (Box of 1's) | Rx | Agio Pharmaceuticals Ltd.India | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-3840 | Nov 22, 2028 | |
MupibanMupirocin (as calcium) | 20 mg/g (2% w/w) Topical CreamAluminum tube x 5 g (Box of 1's) | OTC | Agio Pharmaceuticals Ltd.India | Ambica International Corporation | DRP-7979 | Oct 9, 2028 | |
MupibroMupirocin | 20 mg/g (2% w/w) OintmentCollapsible Aluminum Tube x 5 g (Box of 1's) | OTC | Magbro Healthcare Pvt. Ltd.India | Teramedix Pharma Trading Inc. | DRP-14268 | Feb 9, 2031 | |
MupicanMupirocin | 20 mg/g (2% w/w) Topical OintmentAluminium Collapsible Tube x 5 g, 10 g, and 15 g (Box of 1's) | OTC | Fredun Pharmaceuticals LimitedIndia | AMB HK Enterprises Inc. | DRP-14544 | Oct 10, 2028 | |
MupicareMupirocin | 20mg/g (2% w/w) Topical Ointment5 g Aluminum Tube with HDPE cap (Box of 1's) | OTC | Opal Laboratories (Pvt.) LimitedPakistan | Medcare PharmaceuticalsImporter: Accesspoint International Trading Inc. | DRP-12991-02 | Nov 14, 2027 | |
MupicentMupirocin | 20 mg/g (2% w/w) OintmentLaminated PE Plastic Tube x 5 g (Box of 1's) | Rx | Scott-Edil Pharmacia LimitedIndia | Central West Medicale Inc.Importer: Greencore Pharma Inc. | DRP-6195-05 | Apr 27, 2031 | |
MupicimedMupirocin | 20 mg/g (2% w/w) Topical OintmentWhite Laminated Plastic Tube with Cap x 5 g, 10 g, and 15 g (Box of 1's) | OTC | S KANT HEALTHCARE LTD.India | GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc. | DRP-15716-01 | Sep 5, 2029 | |
MupicinMupirocin | 20 mg/ g (2% w/w) OintmentCollapsible Aluminum tube x 5 g (Box of 1's); Collapsible Aluminum tube x 10 g (Box of 1's) | OTC | Amherst Laboratories, Inc.Philippines | UNILAB, Inc. | DRP-1138-02 | Jun 7, 2027 | |
MupicinMupirocin | 20 mg/ g (2%) Topical CreamCollapsible aluminum tube with screw cap of 5 grams (Box of 1's) | OTC | Amherst Laboratories, Inc.Philippines | Trader: UNILAB, Inc. | DRP-10774 | Nov 17, 2026Past listed date | |
MupicoreMupirocin | 20 mg/g (2% w/w) Ointment5 g Laminated PE Plastic Tube (Box of 1's) | Rx | Scott-Edil Pharmacia Ltd.India | TGP Pharma Inc.Importer: Greencore Pharma, Inc. | DRP-6195-02 | Apr 16, 2031 | |
MupicortMupirocin | 20 mg/g (2% w/w) OintmentAluminum Tube x 5g | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Solvang Pharmaceuticals, Inc. | DRP-14222 | Apr 24, 2030 | |
MupidermMupirocin | 20 mg/g (2% w/w) Topical OintmentAluminium Collapsible Tube x 5 g, 10 g, and 15 g (Box of 1's) | OTC | Yash Medicare Private LimitedIndia | EON Pharmatek Inc.Trader: I-Care Formulations | DRP-14546 | Oct 10, 2028 | |
MupidermMupirocin | 20 mg/g (2%w/w) OintmentAluminum Collapsible Tube x 5 g, 10 g, 15 g (Box of 1's) | Rx | Curetech SkincareIndia | Eon Pharmatek Inc. | DR-XY45567 | Aug 26, 2031 | |
MupidermMupirocin | 20 mg/g (5% w/w) OintmentAluminum Collapsible Tube x 5 g and 10 g (Box of 1's) | Rx | Helviina Pharmaceuticals Pvt. LtdIndia | EON Pharmtek, Inc. | DR-XY36074 | Jul 20, 2029 | |
Mupifer-CMupirocin | 20 mg/g (2% w/w) Topical Cream15 g Aluminum Tube with HDPE Cap (Box of 1's) | OTC | Opal Laboratories (Pvt.) LimitedPakistan | Ferjan Philippines Inc.Importer: Accesspoint International Trading Inc. | DRP-12992-01 | Nov 14, 2027 | |
MupigardMupirocin | 20 mg/g (2% w/w) OintmentAluminum Tube x 5 g | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vitalink Health Products, Inc. | DRP-9044 | Jun 9, 2030 | |
MupigenMupirocin | 20 mg/g (2% w/w) OintmentCollapsible Aluminum Tube with White Cap x 5 g (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DR-XY44192 | Feb 11, 2030 | |
MupigenMupirocin | 20 mg/g (2% w/w) OintmentCollapsible Aluminum Tube with White Cap x 5 g (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DRP-16442 | Feb 11, 2030 | |
MupihabMupirocin | 20 mg/g OintmentAluminum Tube x 10 g (Box of 1's); Aluminum Tube x 5 g (Box of 1's) | Rx | Tai Guk Pharm. Co., Ltd.Republic of Korea | Importer: H & B Pharma International Inc. | DRP-10034 | Jul 12, 2031 | |
MupilirMupirocin | 20 mg/g (2% w/w) Topical OintmentLaminated Tube x 5 g (Box of 1’s) | OTC | East African (India) OverseasIndia | Elixir Pharma Inc.Importer: Ambica International Corporation | DRP-13828-03 | Apr 27, 2028 | |
MupinMupirocin | 20 mg / g (2% w/w) Topical Ointment5 g Aluminum Tube with HDPE Cap (Box of 1's) | OTC | Opal Laboratories (Pvt.) LimitedPakistan | Base Line Pharma Corp.Importer: Accesspoint International Trading Inc. | DRP-12991-04 | Nov 14, 2027 | |
MupinateMupirocin | 20 mg/g (2% w/w) Ointment5 g Aluminum Tube (Box of 1's) | OTC | Curetech SkincareIndia | Ambica International Corporation | DRP-13368 | Feb 21, 2028 | |
MupiproMupirocin | 20 mg/g (2% w/w) Ointment5-g Aluminum Collapsible Tube with White PE Cap (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India | Base Line Pharma Corp.Importer: Pharmakon Biotec Inc. | DRP-8263-08 | Jul 10, 2029 | |
MupirexMupirocin | 20 mg/g (2% w/w) OintmentLaminated PE Plastic Tube x 5 g (Box of 1's) | Rx | Scott-Edil Pharmacia Ltd.India | Best Remedy Medicines Pharmaceutical Co.Importer: Greencore Pharma, Inc. | DRP-6195-01 | May 8, 2031 | |
MupirivMupirocin | 20 mg/g (2% w/w) Topical OintmentLaminated Tube x 5 g (Box of 1's) | OTC | East African (India) OverseasIndia | Ambica International Corporation | DRP-13828 | Apr 27, 2028 | |
MupirocareMupirocin | 20 mg/g (2% w/w) Topical OintmentAluminum Tube with Cap x 5 g (Box of 1's) | Rx | PSA Chemicals & Pharmaceuticals Pvt. Ltd.India | Bewise Trading Corp. Doing business under the name & style of Pharmaplus Generic & Branded Drug Distributor & Medical SuppliesImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-14964-02 | Mar 7, 2029 | |
MupiroseaMupirocin | 20 mg/g (2% w/w) Ointment5g and 15g Lami Tube (Box of 1's) | Rx | Nanz Med Science Pharma Pvt. Ltd.India | Seapharma International, Inc.Importer: Pharma-Surrey International, Inc. | DRP-13043-01 | Nov 24, 2027 | |
MupiroskinMupirocin | 20 mg/g (2% w/w) ointmentAluminum Tube x 5g (Box of 1's) | Rx | Rhydburg Pharmaceuticals LimitedIndia | RM Lorenzo Pharma & Distribution Inc.Importer: Dreamax IncorporatedTrader: Oak And Zen | DRP-13469-02 | Feb 23, 2028 | |
MUPIROVAMupirocin | 20 mg/g (2% w/w) Topical OintmentLaminated Tube x 5 g (Box of 1’s) | OTC | Helios PharmaceuticalsIndia | RVM Pharma & Medical Supplies DistributionImporter: Suhitas Pharmaceuticals Inc.Trader: Mac Heal Laboratories Ltd. | DRP-14545-02 | Oct 10, 2028 | |
MupirowMupirocin | 20 mg/g (2% w/w) OintmentLaminated Tube X 5 g (Box of 1's) | Rx | Zhejiang Jingwei Pharmaceutical Co., Ltd.China | Aglobal Care, Inc. | DRP-10601 | Oct 21, 2031 | |
MupirozilsMupirocin | 20 mg/g (2% w/w) OintmentAluminum Tube x 5g (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Marilz Pharmaceuticals CorporationTrader: Euro-Health Care Exponents, Inc. | DRP-7601-03 | Apr 5, 2031 | |
MupirtectMupirocin | 20 mg/g (2% w/w) Topical Ointment1 Laminated tube x 15 g | OTC | Orbit PharmaceuticalsIndia | Ambica International Corporation | DRP-16295 | Jan 28, 2030 | |
MupiruzanMupirocin | 20 mg/g (2%w/w) Topical OintmentAluminum Tube with White Screw Cap x 5g, 10g, 15g, 20g (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Triple 888 Medical And Pharma Inc. | DRP-17272-01 | Nov 5, 2030 | |
MupirvMupirocin | 20 mg/g (2% w/w) Ointment5 g Aluminum Collapsible Tube with White PE Cap (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India | RV Group Phil. BranchImporter: Pharmakon Biotec Inc. | DRP-8263-09 | Jul 10, 2029 | |
MupisaphMupirocin | 20mg/g (2% w/w) Topical CreamCollapsible Aluminum Tube x 5 g, 10 g and 15 g (Box of l’s) | OTC | Azine Healthcare Pvt. Ltd.India | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-10840 | Dec 28, 2026 | |
MupisaveMupirocin | 20 mg/g (2% w/w) Topical OintmentAluminum Tube with HDPE Cap x 5g and 15g (Box of 1's) | OTC | Opal Laboratories (Pvt.) LimitedPakistan | Savelink Pharma And Trading Co.Importer: Accesspoint International Trading Inc. | DRP-12991-07 | Nov 14, 2027 | |
MupisenzMupirocin | 20 mg/g OintmentAluminum Tube x 10 g Box of 1's; Aluminum Tube x 5 g Box of 1's | OTC | Tai Guk Pharm. Co., Ltd.Republic of Korea | Pharmaessence Inc.Importer: H & B Pharma International Inc. | DRP-10034-01 | Oct 29, 2031 | |
MupiskyMupirocin | 20 mg/g (2% w/w) Topical OintmentWhite Laminated Plastic Tube with Cap x 5 g, 10 g, and 15 g (Box of 1's) | OTC | S Kant Healthcare Ltd.India | Skymed Pharma DistributorImporter: Medinova Pharmaceutical, Inc. | DRP-15716-04 | Sep 5, 2029 | |
MupisoftMupirocin | 20mg/g (2% w/w/) OintmentAluminum Tube x 5g (Box of 1's) | Rx | KLM Laboratories Pvt. Ltd.India | AMB HK Enterprises, Inc.Importer: AMB HK Enterprises Inc. | DRP-13921 | May 17, 2028 | |
MupistarMupirocin | 20 mg/g (2% w/w) Topical Ointment.Laminated tube x 5 g (Box of 1's) | OTC | S Kant Healthcare Ltd.India | Pharmastar Int't Trading Corp. | DRP-14665 | Nov 21, 2028 | |
MupisurMupirocin | 20 mg/g (2% w/w) CreamLami Tube x 5g & 15g | OTC | Kwality Pharmaceuticals LimitedIndia | Pharma-Surrey International, Inc. | DRP-15022 | Apr 4, 2029 | |
MupivarozMupirocin | 20 mg/g (2% w/w) Topical OintmentAluminum Tube with Cap x 5 g and 15 g (Box of 1's) | OTC | PSA Chemicals & Pharmaceuticals Pvt. Ltd.India | Varoz MarketingImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-14964-01 | Mar 7, 2029 | |
MupivaxMupirocin | 20 mg/g (2% w/w) Topical OintmentLaminated Tube x 5g (Box of 1’s) | OTC | East African (India) OverseasIndia | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-13828-02 | Apr 27, 2028 | |
MupivitaMupirocin | 20 mg /g (2% w/w) Topical OintmentLaminated Tube x 5 g (Box of 1’s) | OTC | Helios Pharmaceuticals (Division of P.K.T.P. Private Limited)India | Vitalife Pharma & Medical Supply Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: Mac Heal Laboratories Ltd. | DRP-14545-03 | Oct 10, 2028 | |
MupivitaMupirocin | 20 mg/g (2% w/w) OintmentAluminum Collapsible Tube x 5g (Box of 1's) | OTC | National Healthcare Pvt. Ltd.Nepal | Vitalife Pharma & Medical Supply Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-16445-03 | Mar 13, 2030 | |
MupiwellMupirocin | 20 mg/g (2% w/w) Topical OintmentAluminum Tube with Cap x 5 g (Box of 1's) | OTC | Hubei Humanwell Chengtain Pharmaceuticals Co., Ltd.China | Sandoval Distributors, Inc. | DRP-14516 | Oct 2, 2028 | |
MupizeeMupirocin | 20 mg/g (2% w/w) OintmentAluminium Tube x 10 g (Box of 1's) | OTC | Zee Laboratories LimitedIndia | Importer: EON Pharmatek Inc. | DR-XY48692 | Apr 13, 2028 | |
MuporigMupirocin | 20 mg/g (2% w/w) OintmentLaminated Tube x 1’s (Box of 1’s) | OTC | Next Wave (India)India | AGB Pharmaceutical Trading and Consultancy Corporation | DRP-11625 | Apr 4, 2032 | |
MuporsMupirocin | 20mg/g (2% w/w) Topical OintmentAluminum Collapsible x 20g (Box of 1's) Aluminum Collapsible tube x 5 g and 15g (Box of 1's) | OTC | Kwality Pharmaceutical Ltd.India | PORS Pharma Trading | DRP-13057 | Nov 23, 2027 | |
MupremixMupirocin | 20 mg / g (2% w/w) Topical OintmentLaminated Tube x 5 g (Box of 1’s) | OTC | Helios Pharmaceuticals (Division of P.K.T.P. Private Limited)India | Premier Pharmaceuticals Marketing Corp.Importer: Suhitas Pharmaceuticals Inc.Trader: Mac Heal Laboratories Ltd. | DRP-14545-05 | Oct 10, 2028 | |
MupremixMupirocin | 20 mg/g (2% w/w) Topical OintmentAluminium Collapsible Tube x 5 g, 10 g, and 15 g (Box of 1’s) | OTC | Fredun Pharmaceuticals LimitedIndia | Premier Pharmaceuticals Marketing Corp.Importer: AMB HK Enterprises Inc. | DRP-14544-01 | Oct 10, 2028 | |
MuprivexMupirocin | 20MG/G (2% w/w) OintmentLaminated Aluminum Tube 5 g and 10 g (Box of 1's) | OTC | Yash PharmaceuticalsIndia | Importer: VE Pharma Inc.Trader: Vexxa Lifesciences Pvt. Ltd. | DR-XY48722 | May 26, 2028 | |
MuprixineMupirocin | 20 mg/g (2% w/w) Topical OintmentAluminum Tube with Cap x 5 g and 15 g (Box of 1's) | OTC | PSA Chemicals & Pharmaceuticals Pvt. Ltd.India | Ambica International Corporation.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-14964 | Mar 7, 2029 | |
MuprosMupirocin | 20 mg/g (2% w/w) OintmentLaminated Tube with Round Cap x 10 g (Box of 1's) | OTC | East African (India) OverseasIndia | Intermac Pharmaceutical Inc. | DRP-14759 | Dec 21, 2028 | |
MuropharMupirocin | 20 mg/g (2% w/w) Ointment5-g Aluminum Collapsible Tube with White PE Cap (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India | Pharmakon Biotec Inc. | DRP-8263 | Jul 10, 2029 | |
MutigocinMupirocin | 20 mg/g (2% w/w) Ointment5 g Aluminum Tube (Box of 1's) | Rx | Agio Pharmaceuticals Ltd.India | Multicare Pharmaceuticals Phils. Inc.Importer: Ambica International Corporation | DRP-3840-13 | Nov 22, 2028 | |
NatribanMupirocin | 20 mg/g (2% w/w) Topical OintmentLaminated PE Tube x 5 g, 10 g and 15g (Box of 1's) | OTC | Mascot Health Series Pvt. Ltd.India | H.N.M. Pharmaceutical TradingImporter: Wellchem Pharmaceutical Products | DRP-11277-02 | Feb 22, 2027 | |
NobacrinMupirocin | 20 mg per gram (2% w/w) OintmentAluminum Tube x 5 g (Box of 1's) | Rx | Front Pharmaceutical PLCChina | Hexagon Pharmaceuticals | DRP-11652 | Jul 14, 2030 | |
noneMupirocin | 2% w/w (2g / 100g) Topical OintmentCollapsible Aluminum Tube 5g (Box of 1's) | OTC | Glenmark Pharmaceuticals Ltd.India | Watsons Personal Care Stores (Philippines) Inc.Importer: Glenmark Philippines, Inc. | DRP-3686-02 | May 26, 2031 | |
NoneMupirocin | 20 mg / g (2 % w/w) OintmentAluminum Collapsible Tube x 15 g (Box of 1's) | Rx | SM Pharmaceuticals SDN. BHD.Malaysia | Endure Medical, Inc.Importer: Phil. Pharmawealth, Inc. | DRP-15312-01 | Jun 18, 2029 | |
NoneMupirocin | 20 mg/g (2% w/w) OintmentAluminum Tube x 5 g | Rx | Lloyd Laboratories, Inc.Philippines | St. Joseph DrugstoreTrader: Solvang Pharmaceuticals, Inc. | DRP-14222-01 | Apr 24, 2030 | |
NoneMupirocin | 20 mg/g (2% w/w) Ointment5 g Aluminum Tube (Box of 1's) | Rx | Agio Pharmaceuticals Ltd.India | Actimed, Inc.Importer: Ambica International Corporation | DRP-3840-05 | Nov 22, 2028 | |
NoneMupirocin | 20 mg/g (2% w/w) Ointment5 g Aluminum Tube (Box of 1's) | Rx | Agio Pharmaceuticals Ltd.India | Watsons Personal Care Stores (Philippines), Inc.Importer: Ambica International Corporation | DRP-3840-06 | Nov 22, 2028 | |
NoneMupirocin | 20 mg/g (2% w/w) Ointment5-g Aluminum Collapsible Tube with White PE Cap (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India | Alkem Laboratories CorporationImporter: Pharmakon Biotec Inc. | DRP-8263-11 | Jul 10, 2029 | |
NoneMupirocin | 20 mg/g (2% w/w) Topical OintmentAluminum Tube with HDPE Cap x 5g (Box of 1's) | OTC | Opal Laboratories (Pvt) Ltd.Pakistan | Reta DrugImporter: Accesspoint International Trading Inc. | DRP-12991-06 | Nov 14, 2027 | |
NoneMupirocin | 20 mg/g (2% w/w) Topical OintmentLaminated Tube x 5 g (Box of 1's) | OTC | East African (India) OverseasIndia | Reta DrugImporter: Ambica International Corporation | DRP-13828-04 | Apr 27, 2028 | |
NoneMupirocin | 20 mg/g OintmentAluminum Collapsible Tube x 5 g (Box of 1's) | OTC | GENUONE Sciences Inc.Republic of Korea | Ritemed Phils., Inc. | DRP-6115 | Apr 14, 2031 | |
OranclearMupirocin | 20 mg/g (2% w/w) OintmentAluminum Collapsible Tube x 5g (Box of 1's) | OTC | National Healthcare Pvt. Ltd.Nepal | Orange Biotec Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-16445-01 | Mar 13, 2030 | |
OranclearMupirocin | 20 mg/g (2% w/w) Topical OintmentLaminated Tube x 5 g (Box of 1's) | OTC | Helios Pharmaceuticals (Division of P.K.T.P. Private Limited)India | Orange Biotec Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: Mac Heal Laboratories Ltd. | DRP-14545-01 | Oct 10, 2028 | |
PelisafeMupirocin | 20mg/g (2% w/w) Topical OintmentLaminated Tube x 5 g (Box of 1's) | OTC | Helios PharmaceuticalsIndia | Suhitas Pharmaceuticals Inc.Trader: Mac Heal Laboratories Ltd. | DRP-14545 | Oct 10, 2028 | |
PillpirocinMupirocin | 20 mg/g (2% w/w) Topical OintmentAluminum Tube with Cap x 5 g and 15 g (Box of 1's) | OTC | PSA Chemicals & Pharmaceuticals Pvt. Ltd.India | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-14964-04 | Mar 7, 2029 | |
PirocinMupirocin | 20 mg/g (2% w/w) OintmentCollapsible Plastic Tube x 5 g, 10 g and 15 g (Box of 1's) | Rx | Zee Laboratories LimitedIndia | Eon Pharmatek Inc. | DR-XY46245 | Feb 7, 2028 | |
PiroMedMupirocin | 20 mg/g (2% w/w) OintmentAluminum Tube x 5g (Box of 1's) | Rx | Rhydburg Pharmaceuticals Ltd.India | Dreamax IncorporatedTrader: Mitriva Healthcare Pvt. Ltd. | DRP-13469 | Feb 23, 2028 | |
PiromumaxMupirocin | 20 mg/g (2% w/w) OintmentLaminated Tube x 1's (Box of 1's) | OTC | Next Wave (India)India | Afree Pharmaceutical Distribution Corp.Importer: Bliss Pharma Distribution and Consultancy Corp. | DRP-11625-02 | Apr 4, 2027 | |
PolericinMupirocin | 20mg/g (2% w/w) CreamLami Tube x 5g & 15 g N/A | OTC | Kwality Pharmaceuticals LimitedIndia | Nemrac Medical and Pharma Supplies Corp.Importer: Pharma-Surrey International, Inc. | DRP-15022-01 | Apr 4, 2029 | |
PriadixMupirocin | 20 mg/g (2% w/w) Ointment5-g Aluminum Collapsible Tube with White PE Cap (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-8263-03 | Jul 10, 2029 | |
ProcinMupirocin | 20 mg/g (2% w/w) Ointment5 g collapsible aluminum tube (Box of 1's) | Rx | Front Pharmaceuticals PLCChina | Trumed PharmaceuticalsImporter: Hexagon Pharmaceuticals | DR-XY47488 | Oct 22, 2036 | |
ProdermMupirocin | 20 mg/g (2% w/w) OintmentAluminum Tube x 5 g (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Meedpharma Medical Supplies & Equipment DistributorTrader: Euro-Health Care Exponents, Inc. | DRP-7601 | Apr 24, 2030 | |
ProdixMupirocin | 20 mg/g (2% w/w) OintmentCollapsible Aluminum Tube x 5 g (Box of 1's) | OTC | Magbro Healthcare Pvt. Ltd.India | Bansan Pharma DistributorImporter: Teramedix Pharma Trading Inc. | DRP-14268-01 | Mar 2, 2031 | |
PrupricinMupirocin | 20 mg/g (2% w/w) Ointment5 g Aluminum Tube (Box of 1's) | Rx | Agio Pharmaceuticals Ltd.India | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation | DRP-3840-12 | Nov 22, 2028 | |
PucinfreeMupirocin | 20 mg/g (2% w/w) OintmentLaminated Tube x 1's (Box of 1's) | OTC | Next Wave (India)India | Afree Pharmaceutical Distribution Corp.Importer: Bliss Pharma Distribution and Consultancy Corp. | DRP-11625-01 | Apr 4, 2027 | |
PurexinMupirocin | 20 mg/g (2% w/w) Ointment5 g and 15 g Lami Tube (Box of 1's) | Rx | Nanz Med Science Pharma Pvt. Ltd.India | Rexmed Pharmaceutical SalesImporter: Pharma-Surrey International, Inc. | DRP-13043-02 | Nov 24, 2027 | |
RetaprobanMupirocin | 20 mg/g (2% w/w) OintmentLaminated Tube x 5 g (Box of 1's) | OTC | Zhejiang Jingwei Pharmaceutical Co., Ltd.China | Reta DrugImporter: Aglobal Care, Inc. | DRP-10601-01 | Oct 21, 2031 | |
Retaproban-RMupirocin | 20 mg / g (2% w/w) Topical OintmentLaminated Tube x 5 g (Box of 1’s) | OTC | Helios Pharmaceuticals(Division Of P.K.T.P. Private Limited)India | Reta DrugImporter: Suhitas Pharmaceuticals Inc.Trader: Mac Heal Laboratories Ltd. | DRP-14545-04 | Oct 10, 2028 | |
Retaproban-RMupirocin | 20 mg/g (2% w/w) OintmentAluminum Collapsible Tube x 5 g (Box of 1's) | OTC | National Healthcare Pvt. Ltd.Nepal | Reta DrugImporter: Suhitas Pharmaceuticals Inc. | DRP-16445-02 | Mar 13, 2030 | |
Retaproban-RMupirocin | 20 mg/g (2% w/w) Topical OintmentWhite Laminated Plastic Tube with Cap x 5 g, 10 g, and 15 g (Box of 1's) | OTC | S Kant Healthcare Ltd.India | Reta DrugImporter: Medinova Pharmaceutical Inc. | DRP-15716-02 | Sep 5, 2029 | |
RextrocinMupirocin | 20mg /g (2% w/w) Topical OintmentAluminum Tube with HDPE cap x 5g, 10g, 15g (Box of 1's) | OTC | Opal Laboratories (Pvt.) LimitedPakistan | Rexmed Pharmaceutical SalesImporter: Accesspoint International Trading Inc. | DRP-12991-03 | Nov 14, 2027 | |
RitolMupirocin | 20mg/g (2%w/w) Topical OintmentAluminum Collapsible Tube x 15g and 5 g (Box of 1's) | Rx | Rhydburg Pharmaceuticals Ltd.India | Genedrift Philippines OPC | DRP-13957 | Jun 8, 2028 | |
RocinferMupirocin | 20 mg/g (2% w/w) Ointment5-g Aluminum Collapsible Tube with White PE Cap (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India 174101 | Ferma Drug EnterprisesImporter: Pharmakon Biotec Inc. | DRP-8263-17 | Jul 10, 2029 | |
RosenMupirocin | 20 mg/g (2% w/w) OintmentAluminum Tube x 5g and 10g Box of 1's | Rx | Biopharma Laboratories LimitedBangladesh | All-Bio Pharma, Inc.Importer: JF Draf Pharmaceuticals Corporation | DRP-3672-02 | Mar 20, 2027 | |
RupiroMupirocin | 20 mg/g (2% w/w) OintmentCollapsible aluminum tube with white PET screw cap x 5 g (Box of 1's) | Rx | Front Pharmaceutical PLCChina | AMB HK Enterprises Inc. | DRP-17430 | Jan 20, 2031 | |
S-TrobanMupirocin | 20 mg/g (2% w/w) Ointment5 g Aluminum Tube (Box of 1's) | Rx | Agio Pharmaceuticals Ltd.India | Starpharm, Inc.Importer: Ambica International Corporation | DRP-3840-11 | Nov 22, 2028 | |
S-TrobanMupirocin | 20 mg/g (2%w/w) Topical OintmentAluminum Tube with White Screw Cap x 5g, 10g, 15g and 20g (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories, Inc.Philippines | Starpharm, Inc. | DRP-17272-02 | Nov 5, 2030 | |
SaphirocinMupirocin | 20 mg/g (2% W/W) Topical OintmentAluminum Collapsible Tube x 5 g, 10 g, 15 g , 20 g , and 30 g (Box of 1's) | OTC | Sai Parenterals Ltd.India | Ollen Pharma Trading Inc. | DRP-18389 | Jul 1, 2031 | |
TieradixMupirocin | 20 mg/g (2% w/w) Ointment5-g Aluminum Collapsible Tube with White PE Cap (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India | 999 Seth Pharmaceutical Inc.Importer: Pharmakon Biotec Inc. | DRP-8263-04 | Jul 10, 2029 | |
TopanticMupirocin | 20 mg/g (2% w/w) OintmentAluminum Collapsible Tube x 5g & 10g (Box of 1's) | OTC | National Healthcare Pvt. Ltd.Nepal | Suhitas Pharmaceuticals Inc. | DRP-16445 | Mar 13, 2030 | |
UnbrandedMupirocin | 20 mg/g (2% w/w) OintmentLaminated PE Plastic Tube x 5 g and 15 g (Box of 1's) | Rx | Scott-Edil Pharmacia LimitedIndia | South Star DrugImporter: Greencore Pharma Inc. | DRP-6195-06 | Jun 24, 2031 | |
WestmicinMupirocin | 20 mg/g (2% w/w) Ointment5 g Aluminum Tube (Box of 1's) | Rx | Agio Pharmaceuticals Ltd.India | Westpoint Pharma Inc.Importer: Ambica International Corporation | DRP-3840-14 | Nov 22, 2028 | |
WudencinMupirocin | 20 mg/g (2% w/w) OintmentAluminum Collapsible Tube with White PE Cap x 5g (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-8263-06 | Jul 10, 2029 | |
(no brand name)Mupirocin | 20 mg/g (2% w/w) Ointment | Rx | Marine Life SciencesIndia | Airlife International Trading Corporation | DRP-17650 | Feb 11, 2031 | |
(no brand name)Mupirocin | 20 mg/g (2% w/w) Topical OintmentCollapsible Aluminum Tube x 15 g (Box of 1's) | OTC | Glenmark Pharmaceuticals Ltd.India | Glenmark Philippines, Inc. | DRP-11977 | May 25, 2027 | |
(no brand name)Mupirocin | 20 mg/g (2% w/w) Topical OintmentAluminium Collapsible Tube x 5 g (Box of 1' s) | OTC | Agio Pharmaceuticals Ltd.India | Ambica International Corporation | DRP-14210 | Jul 26, 2028 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
United States (label)
Dosage forms and strengths (US label) US FDA label
3 DOSAGE FORMS AND STRENGTHS PIRNUO TM Cream (Mupirocin Cream USP, 2%) is a white cream that contains 20 mg (2% w/w) of mupirocin per gram (equivalent to 21.5 mg (2.15% w/w) of mupirocin calcium, USP) in an oil- and water-based emulsion, supplied in 42.5 gram pumps. Cream: 20 mg (2% w/w) of mupirocin per gram (equivalent to 21.5 mg (2.15% w/w) of mupirocin calcium, USP) in 42.5-gram pumps. (3)
Warnings/Precautions
- • Severe Allergic Reactions: Anaphylaxis, urticaria, angioedema, and generalized rash have been reported in patients treated with formulations of mupirocin, including mupirocin cream. (5.1)
- • Eye Irritation: Avoid contact with eyes. (5.2)
- • Local Irritation: Discontinue in the event of sensitization or severe local irritation. (5.3)
- • Clostridium difficile -Associated Diarrhea (CDAD): If diarrhea occurs, evaluate patients for CDAD. (5.4)
- • Potential for Microbial Overgrowth: Prolonged use may result in overgrowth of nonsusceptible microorganisms, including fungi. (5.5)
- • Risk Associated with Mucosal Use: PIRNUO cream is not formulated for use on mucosal surfaces. A separate formulation, BACTROBAN nasal ointment, is available for intranasal use. (5.6)
5.1 Severe Allergic Reactions
5.1 Severe Allergic Reactions Systemic allergic reactions, including anaphylaxis, urticaria, angioedema, and generalized rash, have been reported in patients treated with formulations of mupirocin, including mupirocin cream [see Adverse Reactions (6.2)].
5.2 Eye Irritation
5.2 Eye Irritation Avoid contact with the eyes. In case of accidental contact, rinse well with water.
5.3 Local Irritation
5.3 Local Irritation In the event of a sensitization or severe local irritation from PIRNUO cream, usage should be discontinued, and appropriate alternative therapy for the infection instituted.
5.4 Clostridium difficile
5.4 Clostridium difficile -Associated Diarrhea Clostridium difficile -associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile.
C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxin-producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhea following antibacterial drug use.
Careful medical history is necessary since CDAD has been reported to occur over 2 months after the administration of antibacterial agents. If CDAD is suspected or confirmed, ongoing antibacterial drug use not directed against C. difficile may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibacterial treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated.
5.5 Potential for Microbial Overgrowth
5.5 Potential for Microbial Overgrowth As with other antibacterial products, prolonged use of PIRNUO cream may result in overgrowth of nonsusceptible microorganisms, including fungi [see Dosage and Administration (2)].
5.6 Risk Associated with Mucosal Use
5.6 Risk Associated with Mucosal Use PIRNUO cream is not formulated for use on mucosal surfaces. A separate formulation, BACTROBAN(mupirocin) nasal ointment, is available for intranasal use.
Adverse reactions
- The following adverse reactions are discussed in more detail in other sections of the labeling: • Severe Allergic Reactions [see Warnings and Precautions (5.1)] • Eye Irritation [see Warnings and Precautions (5.2)] • Local Irritation [see Warnings and Precautions (5.3)] • Clostridium difficile -Associated Diarrhea [see Warnings and Precautions (5.4)] • The most frequent adverse reactions (at least 1%) were headache, rash, and nausea. (6.1)
- To report SUSPECTED ADVERSE REACTIONS, contact Glenmark Pharmaceuticals Inc., USA at 1 (888) 721-7115 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
6.1 Clinical Trials Experience
6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in practice. In 2 randomized, double-blind, double-dummy trials, 339 subjects were treated with topical mupirocin cream plus oral placebo.
Adverse reactions occurred in 28 (8.3%) subjects. The following adverse reactions were reported by at least 1% of subjects in connection with the use of mupirocin cream in clinical trials: headache (1.7%), rash (1.1%), and nausea (1.1%). Other adverse reactions which occurred in less than 1% of subjects were: abdominal pain, burning at application site, cellulitis, dermatitis, dizziness, pruritus, secondary wound infection, and ulcerative stomatitis.
In a supportive trial in the treatment of secondarily infected eczema, 82 subjects were treated with mupirocin cream. The incidence of adverse reactions was as follows: nausea (4.9%), headache and burning at application site (3.6% each), pruritus (2.4%), and 1 report each of abdominal pain, bleeding secondary to eczema, pain secondary to eczema, hives, dry skin, and rash.
6.2 Postmarketing Experience
6.2 Postmarketing Experience In addition to adverse reactions reported from clinical trials, the following reactions have been identified during postmarketing use of mupirocin cream. Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made. These reactions have been chosen for inclusion due to a combination of their seriousness, frequency of reporting, or potential causal relationship to mupirocin cream.
Immune System Disorders Systemic allergic reactions, including anaphylaxis, urticaria, angioedema, and generalized rash [see Warnings and Precautions (5.1)].
Pregnancy considerations
Pregnancy (US label) US FDA label
8.1 Pregnancy Risk Summary There are insufficient human data to establish whether there is a drug-associated risk with mupirocin cream in pregnant women. Systemic absorption of mupirocin through intact human skin is minimal following topical administration of mupirocin cream [see Clinical Pharmacology (12.3)]. No developmental toxicity was observed in rats or rabbits treated with mupirocin subcutaneously during organogenesis at doses of 160 or 40 mg per kg per day, respectively (22 and 11 times the human topical dose based on calculations of dose divided by the entire body surface area).
The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. The estimated background risk in the U.S. general population of major birth defects is 2% to 4% and of miscarriage is 15% to 20% of clinically recognized pregnancies. Data Animal Data: Developmental toxicity studies have been performed with mupirocin administered subcutaneously to rats and rabbits at doses up to 160 mg per kg per day during organogenesis.
This dose is 22 and 43 times, respectively, the human topical dose (approximately 60 mg mupirocin per day) based on calculations of dose divided by the entire body surface area. Maternal toxicity was observed (body weight loss/decreased body weight gain and reduced feeding) in both species with no evidence of developmental toxicity in rats.
In rabbits, excessive maternal toxicity at the high dose precluded the evaluation of fetal outcomes. There was no developmental toxicity in rabbits at 40 mg per kg per day, 11 times the human topical dose based on calculations of dose divided by the entire body surface area. Mupirocin administered subcutaneously to rats in a pre- and postnatal development study (dosed during late gestation through lactation) was associated with reduced offspring viability in the early postnatal period at a dose of 106.7 mg per kg, in the presence of injection site irritation and/or subcutaneous hemorrhaging.
This dose is 14 times the human topical dose based on calculations of dose divided by the entire body surface area. The no-observed adverse effect level in this study was 44.2 mg per kg per day, which is 6 times the human topical dose.
Mechanism of action
12.1 Mechanism of Action Mupirocin is an RNA synthetase inhibitor antibacterial [see Microbiology (12.4)].
US FDA labelPharmacokinetics
Data from this trial indicated more frequent occurrence of percutaneous absorption in children (90% of subjects) compared with adults (44% of subjects); however, the observed urinary concentrations in children (0.07 to 1.3 mcg per mL [1 pediatric subject had no detectable level]) are within the observed range (0.08 to 10.03 mcg per mL [9 adults had no detectable level]) in the adult population.
Elimination In a trial conducted in 7 healthy adult male subjects, the elimination half-life after intravenous administration of mupirocin was 20 to 40 minutes for mupirocin and 30 to 80 minutes for monic acid.
Excretion: Monic acid is predominantly eliminated by renal excretion.
Pharmacokinetics (US label) US FDA label
12.3 Pharmacokinetics Absorption Systemic absorption of mupirocin through intact human skin is minimal. The systemic absorption of mupirocin was studied following application of mupirocin cream 3 times daily for 5 days to various skin lesions greater than 10 cm in length or 100 cm 2 in area in 16 adults (aged 29 to 60 years) and 10 children (aged 3 to 12 years).
Some systemic absorption was observed as evidenced by the detection of the metabolite, monic acid, in urine. Data from this trial indicated more frequent occurrence of percutaneous absorption in children (90% of subjects) compared with adults (44% of subjects); however, the observed urinary concentrations in children (0.07 to 1.3 mcg per mL [1 pediatric subject had no detectable level]) are within the observed range (0.08 to 10.03 mcg per mL [9 adults had no detectable level]) in the adult population.
In general, the degree of percutaneous absorption following multiple dosing appears to be minimal in adults and children. The effect of the concurrent application of mupirocin cream with other topical products has not been studied [see Dosage and Administration (2)]. Elimination In a trial conducted in 7 healthy adult male subjects, the elimination half-life after intravenous administration of mupirocin was 20 to 40 minutes for mupirocin and 30 to 80 minutes for monic acid.
Metabolism: Following intravenous or oral administration, mupirocin is rapidly metabolized. The principal metabolite, monic acid, demonstrates no antibacterial activity. Excretion: Monic acid is predominantly eliminated by renal excretion.
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Mupirocin Cream 2%, 15 g Tube | ₱93.33–₱150.00Reference ₱136.88 | per tube | DPRI procurement range |
| Mupirocin Ointment 2%, 15 g Tube | ₱60.00–₱134.33Reference ₱104.00 | per tube | DPRI procurement range |
| Mupirocin Ointment 2%, 5 g Tube | ₱38.33–₱98.80Reference ₱44.33 | per tube | DPRI procurement range |
Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
Formulary and coverage
| Philippine National Formulary | Listed as Mupirocin |
| PNF listing | Cream: 2%, 5 g sachet and 15 g tube |
| PNF listing | Ointment: 2%, 5 g and 15 g tube |
| PhilHealth GAMOT | No |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. Pirnuo · Glenmark Pharmaceuticals Inc., USA [US FDA-approved label, version 2, March 20, 2020]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89c43f7b-1a88-45bf-a356-07518d4e7870
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .
